Finance

Lists
Why is ACIU up 8,16%?
Dive Deeper
ACIU:NASDAQ
AC Immune AG
2,83 USD
+8,16%
(+0,21) 1D
1-окт., 15:26:36 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACIU...
Open
2,64 USD
High
2,84 USD
Low
2,57 USD
Mkt. cap
288,41 млн
Avg. vol.
191,22 миң
Volume
248,02 миң
52-wk high
4,00 USD
52-wk low
2,10 USD
EPS
-0,52 USD
Beta
1,60
Shares outstanding
101,77 млн
No. of employees
106
Open
2,64 USD
High
2,84 USD
Low
2,57 USD
Mkt. cap
288,41 млн
Avg. vol.
191,22 миң
Volume
248,02 миң
52-wk high
4,00 USD
52-wk low
2,10 USD
EPS
-0,52 USD
Beta
1,60
Shares outstanding
101,77 млн
No. of employees
106
News stories
From web sources and news partners
About AC Immune AG
CEOAndrea Pfeifer
Employees106
Founded2003
Headquarters-
Sector-
Websiteacimmune.com
Analyst ratings
Based on 2 analysts giving stock ratings to ACIU in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ACIU in the last 3 months.
Highest
Current 2,83 USD
12,00 USD (+323,46%)
Average
10,00 USD (+252,88%)
Lowest
8,00 USD (+182,31%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Fein
H.C. Wainwright
Buy
Maintained
12,00 USD
+323,5%
09/24/2026
Thomas Shrader
BTIG
Buy
Maintained
8,00 USD
+182,3%
08/20/2026
Marc Goodman
Leerink Partners
Buy
Maintained
-
-
04/07/2026
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
939,00 миң
338,00 миң
1,12 млн
15,11 млн
Cost of goods sold
13,07 млн
10,62 млн
11,74 млн
10,48 млн
Cost of revenue
13,07 млн
10,62 млн
11,74 млн
10,48 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,57 млн
4,19 млн
4,17 млн
3,54 млн
Operating expense
3,57 млн
4,12 млн
4,16 млн
3,44 млн
Total operating expenses
16,64 млн
14,74 млн
15,91 млн
13,92 млн
Operating income
-15,70 млн
-14,41 млн
-14,79 млн
1,19 млн
Other non operating income
-
-
-
-
EBT including unusual items
-15,86 млн
-14,37 млн
-14,80 млн
1,87 млн
EBT excluding unusual items
-15,39 млн
-14,38 млн
-14,80 млн
1,87 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-73,00 миң
-11,00 миң
-96,00 миң
Net income
-15,86 млн
-14,37 млн
-14,80 млн
1,87 млн
Net profit margin
-1 688,82%
-4 252,37%
-1 322,70%
12,40%
Earnings per share
-0,16
-0,14
-0,15
0,02
Interest and investment income
366,00 миң
353,00 миң
228,00 миң
171,00 миң
Interest expense
-46,00 миң
-42,00 миң
-65,00 миң
-61,00 миң
Net interest expenses
320,00 миң
311,00 миң
163,00 миң
110,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-15,36 млн
-14,08 млн
-14,44 млн
1,47 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору